Here’s What The Latest Ardelyx Inc (ARDX) Data Means For The Company Going Forward

Ardelyx Inc (NASDAQ:ARDX) just put out data from a phase III study in patients with end stage renal disease, and the company is running up on the back of the news.

Keep Reading →